Reputation of the pharmaceutical industry is based on research on the influence of financial factors, the business image in the media and evaluated by experts in the sector, according to the latest Vietnam Report on results of pharmaceutical companies.
Mekong Capital just announced that the Vietnam Azalea Fund (VAF) successfully divested its 24.99 per cent stake in Traphaco JSC at VND141,500 (US$8.22) per share.
After 10 years, the investment fund of Mekong Capital, a Vietnam-focused private equity firm, has gradually divested itself of investments, especially with the plan to sell 25% stake worth US$S52 million at Traphaco, top 10 prestigious pharmaceutical company of Vietnam, to a pharmaceutical company of South Korea.